Nasdaq
LGND
Ligand Pharmaceuticals Incorporated
- Health Care
- 1 day
- −0.8%
- 1 month
- −6.0%
- 1 year
- +111%
$300.14 · Mkt cap $6.02B
At the 6 Aug 2026 close
Nasdaq
Ligand Pharmaceuticals Incorporated
$300.14 · Mkt cap $6.02B
At the 6 Aug 2026 close
Ligand Pharmaceuticals Incorporated trades under the ticker LGND on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $6.02B. The last closing price was $300.14, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +111%, and −6.0% over the past month. Returns are price returns and exclude dividends.
This page exists because LGND is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.